“…Of the 24 included studies, the target population or intended users of systems were oncology patients,18 22 26 28–30 36 palliative home care patients,33–35 oncology outpatients,27 37 hospice and palliative care patients,24 31 patients undergoing palliative radiotherapy,17 25 a mix of palliative care patients, carers and health professionals,23 brain tumour outpatients,20 patients requiring surgery for cancer,16 patients with cancer with incurable metastatic or locally advanced disease,5 patients receiving chemotherapy for cancer,32 breast cancer survivors,21 patients with cancer with depression and/or pain,19 and a mix of members of the public with pain and people with cancer pain 38…”